Galantamine vs Donepezil in the Treatment of Alzheimer's Disease...Drugs Aging. 2003;20(10):777-89
| Publicado en: | Drugs & Aging Vol. 20; no. 15; pp. 1139 - 1141 |
|---|---|
| Autores principales: | , , |
| Formato: | commentary letter Journal Article |
| Publicado: |
Springer Nature
2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106080846&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106080846 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 1170229X C5B jtl: Drugs & Aging issn: 1170229X maglogo: N pubinfo: dt: 2003 vid: 20 iid: 15 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 106080846 2009392413 10.2165/00002512-200320150-00009 NLM14651439 106080846 ppf: 1139 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Galantamine vs Donepezil in the Treatment of Alzheimer's Disease...Drugs Aging. 2003;20(10):777-89 aug: au: Goldlist B Naglie G Gordon M sug: subj: Alzheimer's Disease Drug Therapy Cholinesterase Inhibitors Therapeutic Use Galanthamine Therapeutic Use Hydrocarbons Therapeutic Use Piperidines Therapeutic Use Clinical Trials pubtype: Academic Journal doctype: commentary letter Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|